Biopark Charleroi Brussels South
6041 GOSSELIES
Belgium
[email protected] bioxodes.com

Bioxodes is a clinical stage company developing a first-in-class drug candidate, Ir-CPI, for the prevention of thrombosis and neuroinflammation in haemorrhagic stroke patients.

About